They have their own platform where they create these antibodies to provide a range of therapeutic options for veterinarians and pet owners. The inspiration for adivo came when Kathrin's dog was diagnosed with cancer, and she realized the lack of treatment options available for pets. Recognizing the increasing importance of pets as family members, adivo aims to bridge the gap in specific treatments for serious diseases or chronic conditions in companion animals.

They utilize cutting-edge technology to modify existing antibodies and make them more compatible with pets' immune systems. Their innovative, fully synthetic and fully canine antibody Fab library allows the generation of highly specific antibodies that mimic the natural IgG repertoire in dogs. With billions of fully species-specific antibodies in their collection, adivo selects the perfect fit for each therapeutic need.

They offer their expertise in antibody generation and lead-candidate selection, and are open to partnering with animal health companies to develop therapeutic antibodies for dogs